Skip to main content
Clinical Trials/CTRI/2023/06/053636
CTRI/2023/06/053636
Not yet recruiting
未知

Assessment Of Pre-treatment Neutrophil Lymphocyte Ratio Among Cervical Cancer Patients And Its Association with Stages Of Cervical Cancer (FIGO), Sociodemographic, Lifestyle And Reproductive Factors.

Vardhman Mahavir Medical College0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
Sponsor
Vardhman Mahavir Medical College
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
Vardhman Mahavir Medical College

Eligibility Criteria

Inclusion Criteria

  • Patients with positive biopsy report of cervical carcinoma at any stage of the disease

Exclusion Criteria

  • Patients who donâ??t have a record of their Pre Treatment Neutrophil lymphocyte Ratio (NLR).
  • Severely ill patients not able to converse.
  • Patients suffering from sepsis.
  • Patients with a positive biopsy for blood cancer.
  • Patients with a history of tuberculosis.
  • Patients with severe wounds.
  • Any other severe inflammation except cervical cancer.
  • Patients with active liver disease, including those with primary biliary cirrhosis and unexplained persistent liver function abnormalities.
  • Any medication or indication that may interfere with the interpretation of study results and, in the judgment of the study personnel, would make the subject inappropriate for inclusion.
  • Patients with history of severe allergies.

Outcomes

Primary Outcomes

Not specified

Similar Trials